Some aspects of treatment of recurrent and bipolar affective disorders
In this article the results of open trial fluoxetine s clinical efficiency at therapy of recurrent and bipolar depressions of the moderate and heavy degree are presented, conclusions are drawn on an optimum mode of dispensing of a preparation, features of clinical dynamics against fluoxetine s therapy are revealed, which, are displayed, also in reducing vital symptoms of depression (firstly astheno-anergetic part) in all age groups.